Leadership

April 26, 2021 Diversity Equity & Inclusion at Alnylam: Building on the Momentum to Create Lasting Impact ... Sara Nochur, Alnylam's Chief Diversity, Equity & Inclusion Officer talks about DE&I at Alnylam and her role leading the company's efforts. Read More ›
March 11, 2021 Alnylam Publishes First Corporate Responsibility Summary Today, we've published Alnylam's first Corporate Responsibility Summary detailing our approach to corporate responsibility and the actions we are and intend to Read More ›
December 7, 2020 Alnylam Publishes Its 1st-Ever Rare Disease Trend Report Alnylam's 2020 Rare Disease Trend Report features findings from interviews with 30 U.S. payer and plan decision-makers about barriers to orphan drug access. Read More ›
October 1, 2020 A New European Biotech Social Pact The European Pact builds on Alnylam’s own pledge, encouraging biotech companies to be a force for good in partnering with European authorities, citizens and... Read More ›
August 6, 2020 Alnylam Promotes Dr. Yvonne Greenstreet to President & COO Dr. Yvonne Greenstreet, has been elevated to the role of President of Alnylam. She will retain her COO role as well. Read More ›
June 15, 2020 Rethinking R&D to Prime it for Future Success Much of the world has this romantic notion that drug discovery involves a small numbers of hero scientists toiling away in a lab until – Eureka! – the breakthro Read More ›
June 9, 2020 John Maraganore in "Biotechnology in the Time of COVID-19: Commentaries from the Front Lin ... In a new e-book, dozens of biopharma industry leaders, including our CEO John Maraganore, share their perspectives from the industry's unique vantage point on t Read More ›
June 7, 2020 Alnylam Leaders at BIO International Convention 2020/"Digital BIO" Even though the BIO International Convention has gone virtual for 2020 as a result of COVID-19, Alnylam leaders will continue to contribute to the informative, Read More ›
February 20, 2019 Alnylam Named a Fast Company World's Most Innovative Company for 2019 Alnylam has been named #3 in Biotech on Fast Company's World's 50 Most Innovative Company for 2019. Read More ›
December 11, 2018 John Maraganore Named to Bloomberg 50 List for 2018 Alnylam CEO John Maraganore has been named to the Bloomberg 50 list for 2018. Read More ›

Get In Touch

Have any questions or comments about the content you see on this page?

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site